CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Citius Pharmaceuticals, Inc. - CTXR CFD

    0.9509
    3.3%
    • Summary
    • Historical Data
    Trading сonditions
    Spread 0.0087
    Long position overnight fee

    Long position overnight funding adjustment

    Margin. Your investment $1,000.00
    Overnight funding adjustment -0.02629 %
    Charges from full value of position ($-5.00)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.02629%
    Short position overnight fee

    Short position overnight funding adjustment

    Margin. Your investment $1,000.00
    Overnight funding adjustment 0.004068 %
    Charges from full value of position ($0.77)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004068%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5.00%
    Stock exchange United States of America
    Commission on trade 0%

    Key Stats
    Prev. Close 0.9208
    Open 0.9382
    1-Year Change -17.44%
    Day's Range 0.9182 - 0.9571
    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jul 25, 2024 0.9289 -0.0193 -2.04% 0.9482 0.9488 0.8482
    Jul 24, 2024 0.9264 -0.0318 -3.32% 0.9582 0.9982 0.9105
    Jul 23, 2024 0.9167 0.0635 7.44% 0.8532 0.9502 0.8382
    Jul 22, 2024 0.8493 0.0511 6.40% 0.7982 0.8672 0.7682
    Jul 19, 2024 0.7840 -0.0442 -5.34% 0.8282 0.8283 0.7682
    Jul 18, 2024 0.8248 -0.0034 -0.41% 0.8282 0.8728 0.8182
    Jul 17, 2024 0.8182 -0.0691 -7.79% 0.8873 0.8882 0.7782
    Jul 16, 2024 0.8382 0.0670 8.69% 0.7712 0.8644 0.7682
    Jul 15, 2024 0.7631 0.0248 3.36% 0.7383 0.7731 0.7182
    Jul 12, 2024 0.7253 -0.0419 -5.46% 0.7672 0.7708 0.7133
    Jul 11, 2024 0.7708 0.0026 0.34% 0.7682 0.7872 0.7094
    Jul 10, 2024 0.7333 0.0201 2.82% 0.7132 0.7588 0.6482
    Jul 9, 2024 0.6682 0.0310 4.87% 0.6372 0.6834 0.6082
    Jul 8, 2024 0.6001 0.0519 9.47% 0.5482 0.6094 0.5482
    Jul 5, 2024 0.5233 0.0151 2.97% 0.5082 0.5438 0.4882
    Jul 3, 2024 0.4836 -0.0247 -4.86% 0.5083 0.5212 0.4783
    Jul 2, 2024 0.5129 -0.0364 -6.63% 0.5493 0.5530 0.4982
    Jul 1, 2024 0.5432 -0.0651 -10.70% 0.6083 0.6084 0.5229
    Jun 28, 2024 0.5857 -0.0425 -6.77% 0.6282 0.6432 0.5732
    Jun 27, 2024 0.6316 0.0087 1.40% 0.6229 0.6533 0.6182

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Citius Pharmaceuticals, Inc. Company profile

    Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution for treating patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering with hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, a engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
    Industry: Biotechnology & Medical Research (NEC)

    11 Commerce Dr Fl 1
    CRANFORD
    NEW JERSEY 07016-3501
    US

    News

    How to manage risk when trading

    Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.

    06:57, 22 July 2024

    ECB preview: lack of new data sees markets expecting a hold

    Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise

    13:13, 18 July 2024

    What is an IPO and how does it work?

    Learn about what an IPO is, why they are important, and how they work.

    07:19, 10 July 2024

    What are the biggest stock exchanges worldwide?

    Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.

    12:44, 9 July 2024

    Top ETFs

    ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.

    16:23, 8 July 2024
    Lloyds share price forecast: An attractive dividend stock?

    Lloyds forecast: will Lloyds share price return to £1? Third party data forecast

    What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?

    14:00, 8 July 2024

    RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation

    The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    13:25, 8 July 2024

    People also watch

    BTC/USD

    67,899.75 Price
    +3.940% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 106.00

    ETH/USD

    3,255.79 Price
    +3.270% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 6.00

    US100

    19,029.00 Price
    +1.080% 1D Chg, %
    Long position overnight fee -0.0263%
    Short position overnight fee 0.0041%
    Overnight fee time 21:00 (UTC)
    Spread 7.0

    XRP/USD

    0.60 Price
    +0.560% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01168

    Still looking for a broker you can trust?

    Join the 630,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading